• Lower risk of hip dislocation¹

• More natural walking pattern^1,2

• Greater range of hip motion^1,2

• Easy conversion to a Total Hip Arthroplasty (THA)^1,3

• Targeted as solution for younger and active patients^4,5,6

• Biolox Delta on Biolox Delta Bearing Surface for both the femoral and acetabular components, aiming to eliminate the risk of metal ion release⁷

• Anatomically Contoured, aims to reduce the occurrence of groin pain due to iliopsoas impingement whilst maintaining better coverage angle^8,9

• Fully Cementless Solution with titanium and HA plasma coating, designed to preserve bone, reduce operating time and costs, and aims to provide long-term fixation for active patients¹⁰

Based on the outcomes from the H1 clinical study, it may be suggested that the indications for H1 Hip Resurfacing* could be extended to include:

• Females

• Males older than 65 years

• Patients with femoral head less than 46 mm**

^{*Please refer to the Instruction for Use for the full list of patient indications}

^{**Some manufacturers of metal-on-metal designs suggest to use head diameters > 48 mm}